Wealth Analytics Partners’s Edwards Lifesciences EW Stock Holding History

Wealth Analytics Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$166K	Buy	+1,920	New	+$171K	0.06%	53

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

Ninety One Cape Town, South Africa $2B AUM 34.6% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Wealth Analytics Partners's EW Position: Q3 2026 in Review

Wealth Analytics Partners opened a new position in Edwards Lifesciences (EW) in Q3 2026: 1,920 shares worth $166K. The stake represents 0.06% of the portfolio and ranks #53 among its holdings.

263 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Wealth Analytics Partners held 1,920 shares of Edwards Lifesciences worth $166K as of Q3 2026.
Edwards Lifesciences was a new Wealth Analytics Partners position in Q3 2026.
Edwards Lifesciences made up 0.06% of Wealth Analytics Partners's portfolio in Q3 2026, its #53 holding.
263 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Wealth Analytics Partners's 13F filing for Q3 2026, filed 19 Oct 2026.